-
Mashup Score: 1
Worried about expensive medicine bills? Helping save up to 80% on each prescription, startup Dawa Dost has already reached over 3 million Indian consumers.
Source: The Better IndiaCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 2Incentives For Drug R&D: A Survey Of Biotech Venture Capitalists’ Perspectives | Health Affairs Forefront - 2 year(s) ago
In this article, we summarize major findings from interviews with venture capitalists and discuss how current prescription drug pricing reform efforts address their priorities and concerns.
Source: www.healthaffairs.orgCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
In their new Forefront article Gabriela Gracia @Frank_S_David + @renaconti1 of @BUQuestrom + Pharmagellan summarize findings from interviews with #VentureCapitalists and discuss how current prescription #DrugPricing reform efforts address their priorities. https://t.co/puMl5wejBl
-
-
Mashup Score: 1Waltz Health raises more than $35M for drug cost marketplace and more digital health fundings - 2 year(s) ago
Also: Impiricus raises a $3 million seed, and health tech VC Flare Capital Partners closes its $350 million third fund.
Source: MobiHealthNewsCategories: Healthcare Professionals, Latest HeadlinesTweet-
Waltz Health raises $35M+ for drug cost #marketplace #drugpricing @impiricus raises a $3M seed for #physician dashboard #healthtech #VC @FlareCapital Partners closes its $350M third fund. #digitalhealth fundings https://t.co/aafsmor01q
-
-
Mashup Score: 1
Show Health Affairs This Week, Ep A Health Podyssey: Stacie Dusetzina Shares Why Medicare Beneficiaries May Not Fill Specialty Drug Prescriptions – Apr 21, 2022
Source: Apple PodcastsCategories: Latest Headlines, PayerTweet-
LISTEN: Today on This Week, we are featuring an interview from #AHealthPodyssey. @Health_Affairs Editor-in-Chief @alanrweil interviews @DusetzinaS of @VUMChealth about the complex world of #DrugPricing. Listen & subscribe today: https://t.co/b6F9TE5Fbq https://t.co/yu6Y9UtNj3
-
-
Mashup Score: 0
Healio Rheumatology | In the last 4 years, the three biggest pharmacy benefit managers have consolidated influence in the U.S. health care marketplace through vertical integration with insurance carriers.These transactions have contributed as much, if not more, to skyrocketing prescription drug costs as the pharmaceutical industry itself, according to experts.
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet-
Efforts to contain #PBMs and rein in #DrugPricing has turned into an ever-evolving game of “whack-a-mole,” @MattieRheumMD told @HealioRheum, with PBMs becoming ever more creative at hiding the money https://t.co/gVHHF4GRpi
-
-
Mashup Score: 0Roche, Lilly push back against CMS painting their Alzheimer’s meds with the same brush as Biogen’s Aduhelm - 2 year(s) ago
In a rare moment of solidarity among fierce competitors, Biogen’s peers Roche and Eli Lilly are rallying behind the company’s troubled Alzheimer’s disease therapy, Aduhelm, in an effort to change t | In a rare moment of solidarity among fierce competitors, Biogen’s peers Roche and Eli Lilly are rallying behind the company’s troubled Alzheimer’s disease therapy, Aduhelm, in an effort to change the…
Source: Fierce BiotechCategories: Future of Medicine, Latest HeadlinesTweet-
Roche, Lilly push back against CMS painting their #Alzheimers meds with the same brush as Biogen’s #Aduhelm | #pharma #drugpricing https://t.co/LkzzODnfwo
-
-
Mashup Score: 3Podcast 281: Drug Costs — What’s “The Right Price” for prescription pharmaceuticals? | Clinical Conversations - 2 year(s) ago
Why can’t the U.S. control prescription drug pricing as they do in the U.K., where per-capita spending is less than half our level? In a capitalist democracy, many parties — the drug companies, medical associations, consumer groups — get to lobby their points of view. Is the problem intractable, or just an exercise in chaos? Our three […]
Categories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Drug Costs — What’s “The Right Price” for Prescription Pharmaceuticals? In the latest Clinical Conversations, NEJM Group's Joe Elia discusses the issue with @PeterNeumann11, @jcohen1964, and @dollendorf. Listen in: https://t.co/XIG4yjUL52 #drugpricing https://t.co/7SjXpf31eD
-
-
Mashup Score: 0State Drug Price Transparency - 2 year(s) ago
Operational considerations for manufacturers to understand how to remain compliant as new state drug pricing transparency legislations are enacted.
Source: Deloitte United StatesCategories: Future of Medicine, Latest HeadlinesTweet-
Non-compliance is expensive, in fact it can incur penalties of up to $25,000. Explore operational considerations for #DrugPricing regulation in our #StatePriceTransparency report. https://t.co/Oz8t0WVy8n
-
-
Mashup Score: 0State Drug Price Transparency - 2 year(s) ago
Operational considerations for manufacturers to understand how to remain compliant as new state drug pricing transparency legislations are enacted.
Source: Deloitte United StatesCategories: Future of Medicine, Latest HeadlinesTweet-
Are manufacturers aware of how diverse #DrugPricing regulations are across each state in the US? Download our report to help avoid fines and stay updated. https://t.co/EMmLrVs39j
-
-
Mashup Score: 0
Learn more at https://republicans-oversight.house.gov/
Source: YouTubeCategories: Latest Headlines, RheumatologyTweet-
Tune in to today's @GOPoversight hearing/forum where @MattieRheumMD will be discussing harmful #PBM practices that impact patient access to available and affordable medications @CSROAdvocacy @ACRheum @ATAPAdvocates #DrugReform #DrugPricing https://t.co/IdkbPrpW35
-
#India Mounting Medicine Bills? This #Startup @dawaadost Helps You Save Up To 80% on Each Prescription- has already reached over 3 million Indian consumers. | #pharma #generics #drugpricing https://t.co/FaVB1091HV